$SLBT News
Last published 2w ago
- 2w agoSLBTSL Science Holding Limited Reports First Half 2026 Financial ResultsGlobeNewswireNet revenue rose 23% to $1.39 million with gross margin expanding to 40.2%, driven by B2B distribution growth and reduction in purchase costs compared with last period due to establishment of stable relationships with
- 2mo agoSLBTSL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded CompanyGlobeNewswireNEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- SL Science Holding Limited ("SL Science" or the "Company") (NASDAQ:SLBT), a Taiwan-headquartered biomedical company specializing in developing innovative
- 2mo agoSLBTSL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its PlatformGlobeNewswireTAIPEI, Taiwan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- SL Science Holding Limited ("SL Science" or the "Company") (NASDAQ:SLBT), a Taiwan-headquartered biomedical company specializing in innovative cellular
- 3mo agoSLBTSL Science Leadership Co-Authors Peer-Reviewed Framework for Clinical Development of γδ T Cell Therapy in GlioblastomaGlobeNewswireTAIPEI, Taiwan, Aug. 11, 2026 (GLOBE NEWSWIRE) -- SL Science Holding Limited ("SL Science" or the "Company") (NASDAQ:SLBT), a Taiwan-headquartered biomedical company specializing in developing
- 3mo agoSLBTSL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical PharmacologyGlobeNewswireJoint presentation with Taipei Medical University, JY BioMed, and HeXun Biosciences highlighted the power of gamma delta (γδ) T cells in eliminating glioblastoma in preclinical studies. TAIPEI, TAIWAN, July 17, 2026
- 4mo agoSLBTSL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting GlioblastomaGlobeNewswireTaipei, TAIWAN, July 10, 2026 (GLOBE NEWSWIRE) -- SL Science Holding Limited ("SL Science" or the "Company") (NASDAQ:SLBT), a Taiwan-headquartered biomedical company specializing in developing
- 4mo agoSLBTSL Science Holding Limited Reports Full Year 2025 Financial ResultsGlobeNewswireTaipei, TAIWAN, June 18, 2026 (GLOBE NEWSWIRE) -- SL Science Holding Limited ("SL Science" or the "Company") (NASDAQ:SLBT), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and
- 4mo agoCRVOEWTXNTHISLBTBiotech Bulls Stampede as Clinical Wins and Milestones Fuel MomentumGlobeNewswireDENVER, June 16, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) – Multiple clinical-stage companies are delivering meaningful regulatory, clinical, and corporate milestones. From brain cancer drug development and cell
- 5mo agoHSPTSLBTSL BIO Ltd. and Horizon Space Acquisition II Announce Closing of Business Combination and Listing on the Nasdaq Global MarketGlobeNewswirePost-combination company, SL Science Holding Limited, to commence trading on the Nasdaq Stock Market under the ticker symbol "SLBT"Transaction provides strategic capital to advance proprietary Gamma delta T cell-based